SAN DIEGO, May 2, 2011 /PRNewswire/ — Volcano Corporation
VOLC), a leading developer and manufacturer of precision
intravascular diagnosis and therapy guidance tools designed to
enhance the treatment of coronary and peripheral vascular disease,
said today that it will be participating in the Tenth Annual JMP
Securities Research Conference on Tuesday, May 10.
The presentation by John Dahldorf, chief financial officer, will
begin at 10:30 a.m., Pacific Daylight Time (1:30 p.m., Eastern
The presentation will be available through the conference
website at http://www.wsw.com/webcast/jmp13/volc/
and via the company’s website at www.volcanocorp.com.
Volcano Corporation is revolutionizing the medical device
industry with a broad suite of technologies that make imaging and
therapy simpler, more informative and less invasive. Our products
empower physicians around the world with a new generation of
analytical tools that deliver more meaningful
information—using light and sound as the guiding elements.
Founded in cardiovascular care and expanding into other
specialties, Volcano is changing the assumption about what is
possible in improving patient outcomes by combining imaging and
therapy together. For more information, visit the company’s website